Dr. Antoni Ribas receives American Association for Cancer Research award

Dr. Antoni Ribas has received the Richard and Hinda Rosenthal Memorial Award from the American Association for Cancer Research (AACR). The award honors investigators relatively early in their careers whose research has made, or promises to soon make, a notable contribution to improved clinical care in the field of cancer.

UCLA scientists pinpoint cancer gene responsible for neuroendocrine prostate cancer

Typical prostate cancer cells (left) and neuroendocrine prostate cancer cells.

Typical prostate cancer cells (left) and neuroendocrine prostate cancer cells. The neuroendocrine cells’ disorganized appearance reflects their more aggressive nature.

Advanced cancer detection

New method could lead to better therapies for many deadly cancers

A promising new discovery by UCLA scientists could lead to a new method of identifying cancer patients that express high levels of an enzyme and are more likely to respond to cancer treatments.

UCLA researcher receives largest award in latest round of funding from California’s stem cell agency

Childhood leukemia study

UCLA-led research shows protein could be target for drugs that combat leukemia

UCLA scientists have uncovered how a cellular protein contributes to an aggressive form of leukemia prevalent in young children. The discovery is an important step forward in the effort to better understand and treat aggressive childhood leukemia.

The study was published in the Journal of Clinical Investigation.

Stem cell gene therapy could be key to treating Duchenne muscular dystrophy

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and Center for Duchenne Muscular Dystrophy at UCLA have developed a new approach that could eventually be used to treat Duchenne muscular dystrophy. The stem cell gene therapy could be applicable for 60 percent of people with Duchenne, which affects approximately 1 in 5,000 boys in the U.S. and is the most common fatal childhood genetic disease.

Standard method for deriving stem cells may be better for use in regenerative medicine

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered an important naturally occurring process in the developing human embryo that can be lost when embryonic stem cells are derived in the lab.

Annual Symposium, Feb. 5

UCLA researchers make progress toward healing scarred hearts

Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have uncovered two specific markers that identify a stem cell able to generate heart muscle and the vessels that support heart function. This discovery may eventually aid in identifying ways to use stem cells to regenerate damaged heart tissue after a heart attack.

UCLA Researchers identify stem cells in the main knee ligament, the ACL

A research team led by Dr. Frank Petrigliano, member of the UCLA Broad Stem Cell Research Center, has identified specialized cells that have the potential to regenerate injured ligament tissue in the knee.

The research was published in the Journal of Orthopaedic Research on December 16, 2015.

Pages